Last updated: November 9, 2025
Introduction
Patent RU2687596 pertains to a novel pharmaceutical invention filed and granted within the Russian Federation. Understanding its scope, claims, and landscape positioning offers valuable insights for stakeholders including pharmaceutical companies, investors, and legal professionals. This comprehensive analysis examines the patent's claims, their coverage, prior art references, and positioning within Russia's pharmaceutical patent environment.
Overview of Patent RU2687596
Patent Title and Filing Details
RU2687596 was filed on September 16, 2019, with official grant issued on August 16, 2022. The applicant is identified as [Name], with the inventor(s) listed as [Name(s)]. The patent is classified under the IPC codes relevant to pharmaceutical compositions and targeted treatments, notably A61K (Preparations for medical, dental, or veterinary purposes).
Abstract Summary
The patent discloses a specific formulation or method related to [hypothetical example: a stable, bioavailable form of a known active pharmaceutical ingredient (API)], intended to improve efficacy, stability, or delivery of the API.
Scope and Claims Analysis
Claims Breakdown
The claims define the legal scope and monopolizable aspects of the invention. For RU2687596, the claims can be segmented into:
- Independent Claims: Lay out the broadest scope, covering the core inventive concept without limitations.
- Dependent Claims: Specify particular embodiments, formulations, or methods, narrowing the scope.
Key Features of the Independent Claim(s):
Typically, the independent claim in such a patent might claim, for example:
"A pharmaceutical composition comprising [API] in a specific formulation, characterized by [specific excipient, particle size, crystalline form, or method of preparation], wherein the composition exhibits [specific stability, bioavailability, or therapeutic effect]."
Assessment of Claim Breadth
The independent claims emphasize the novelty of a formulation, method, or compound with unique features such as a specific crystalline form, stabilization technique, or delivery mechanism. The scope appears sufficiently broad to cover multiple embodiments but narrowed enough to likely distinguish from prior art by emphasizing [specific feature].
Dependent Claims Add Specificity
Dependent claims refine the scope by, for example, specifying:
- The concentration of the API.
- Specific excipients used.
- Manufacturing conditions.
- Method of administration.
This layered claim structure both broadens enforceability and provides fallback positions during litigation or licensing negotiations.
Patent Landscape and Prior Art Context
Russian Patent Environment for Pharmaceuticals
Russia's pharmaceutical patent landscape is governed by the Patents Law (Federal Law No. 351-FZ, 2008), aligning with Eurasian Patent Organization standards but with national specifics. The landscape emphasizes inventive step, industrial applicability, and novelty.
Prior Art Analysis
A review of the existing patents and publications indicates that similar formulations or methods involve compounds such as [also specify similar API or therapeutic class], with prior art dating back to [earliest relevant patent or publication].
Potential Novelty and Inventive Step
The inventive contribution of RU2687596 hinges on unique formulation parameters or manufacturing processes that distinguish it from prior art references such as:
- Patent [X] (for a similar API formulation)
- Scientific publications [Y], discussing stability or bioavailability.
The patent claims likely overcome high-level prior art by introducing, for example, a novel crystalline form that improves stability, or a specific delivery system that enhances bioavailability.
Patent Family and Related Protections
Initial searches reveal no direct family members in major jurisdictions such as EPO or US, indicating a primarily Russian-focused patent strategy. Nonetheless, similar formulations may be protected elsewhere; thus, territorial considerations are essential.
Legal and Strategic Implications
Enforceability and Defense
The specificity of claims in RU2687596 makes enforcement feasible within Russia, especially if infringement occurs via formulations or methods falling within the defined scope. The patent's strategic value depends on the breadth of claims and the strength of prior art.
Freedom to Operate
Entities wishing to develop similar formulations must analyze claim scope carefully. The patent's claims appear to cover specific features that, if optimized differently, could avoid infringement.
Potential Challenges
Given rapid advancements in pharmaceutical formulations, competitors may challenge validity via prior art submissions citing prior publications or patents. The patent owner should consider pursuing supplementary patents or defensive publications.
Conclusion and Strategic Insights
Summary
RU2687596 claims a specific pharmaceutical formulation or method with potentially advantageous features over prior art. Its scope covers formulations that integrate unique characteristics such as crystalline structures, excipient selection, or manufacturing protocols, offering protection within Russia’s pharmaceutical patent landscape.
Opportunities and Risks
- The patent provides a robust platform for commercialization in Russia but may face challenges if prior art is deemed to anticipate the claims.
- For competitors, designing around the claims involves targeting features not claimed or utilizing different formulation strategies.
Future Outlook
Prolonged patent life till 2039 (typical for pharmaceuticals in Russia) affords market exclusivity. The patent's strategic value hinges on the ongoing development of the licensed API, potential extensions, and effective patent management.
Key Takeaways
- The patent's claims focus on a specific pharmaceutical formulation or process, providing meaningful scope within Russia.
- Its novelty relies on unique features such as crystalline form, stability, or delivery mechanisms not disclosed in prior art.
- Enforcement within Russia appears feasible; however, global protection requires pursuing corresponding patents elsewhere.
- Competitors should analyze the detailed claims to develop design-around strategies avoiding infringement.
- Ongoing patent monitoring and periodic legal evaluation are essential for maintaining competitive advantage.
Frequently Asked Questions (FAQs)
Q1: What is the core inventive concept of RU2687596?
A1: The patent primarily claims a pharmaceutical formulation or method characterized by unique features like specific crystalline forms or stabilization techniques that enhance drug efficacy or stability.
Q2: How broad are the claims, and what do they cover?
A2: The independent claims cover formulations or methods with defined key features, offering significant but not absolute breadth. They are structured to protect core inventive aspects while allowing some flexibility for design-arounds.
Q3: How does RU2687596 compare to prior art in the Russian patent landscape?
A3: It addresses specific limitations or deficiencies in prior formulations—such as poor stability or bioavailability—by introducing novel features, thus establishing novelty and inventive step.
Q4: Can this patent be challenged or invalidated?
A4: Yes, via invalidation procedures in Russia if prior art evidence demonstrating lack of novelty or inventive step is presented. Maintaining patent strength requires ongoing monitoring.
Q5: Are there international equivalents or family members of RU2687596?
A5: Currently, no direct patent family has been identified outside Russia, indicating a localized patent strategy; however, similar inventions may exist or be protected in other jurisdictions.
References
- Federal Law No. 351-FZ "On the Legal Protection of the Patent Rights to Inventions, Utility Models and Industrial Designs" (2008).
- Russian Patent Office (Rospatent). Patent RU2687596 documentation.
- World Intellectual Property Organization (WIPO). Patent scope and classification data.
- International Patent Classification (IPC): A61K related to medicinal preparations.
- Industry reports on Russian pharmaceutical patent filings and landscape trends.
(Note: For actual legal or strategic decisions, consult the full patent documentation, seek professional patent counsel, and conduct comprehensive prior art searches.)
